MeSH tree: H01.158.100
A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC). According to research published in the March issue of The Journal of Nuclear Medicine, the PET ...
Mar 12, 2025
0
24
UC Santa Cruz neuroscientists aiming to better understand how specific brain connectivity contributes to perception, thoughts, and behavior are leveraging artificial intelligence to enhance their study of brain function. ...
Mar 7, 2025
0
57
A new study by researchers at the Department of Molecular Medicine at SDU sheds light on one of the most severe consequences of stroke: damage to the brain's "cables"—the so-called nerve fibers—which leads to permanent impairments. ...
Jan 24, 2025
0
39
Astrocytes are star-shaped glial cells in the central nervous system that support neuronal function, maintain the blood-brain barrier, and contribute to brain repair and homeostasis. The evolution of these cells throughout ...
Researchers from the George Washington University and the Washington DC Veterans Affairs Medical Center have published a case report that signifies a potential breakthrough in the treatment of an aggressive type of prostate ...
Nov 5, 2024
0
72
Research presented today suggests an artificial intelligence tool called DeepGEM may provide an advancement in genomic testing that offers an accurate, cost-effective, and timely method for gene mutation prediction from histopathology ...
Sep 7, 2024
0
34
The use of artificial intelligence (AI) systems shows promise in medicine, where they can be used to detect diseases earlier, improve treatments, and ease staff workloads. But their performance depends on how well the AI ...
Sep 2, 2024
0
39
An innovative software tool could advance cancer pathology by providing diagnostic insights from tissue biopsies. The tool, called METI (Morphology-Enhanced Spatial Transcriptome Analysis Integrator), was developed by researchers ...
Aug 29, 2024
0
40
The human epidermal growth factor receptor 2 (HER2) is a critical protein in the growth of cancer cells, and its expression level is a vital indicator of breast cancer aggressiveness. Traditionally, HER2 status is assessed ...
Jul 17, 2024
0
31
A new editorial paper titled "HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity" has been published in Oncotarget.
Jul 16, 2024
0
38
